Back to search
FDAFDA · Food and drugs·Recall number D-143-2013

Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30.

Published February 13, 2013 · Recall initiated: January 16, 2013

Summary

FDA records drug Class III recall D-143-2013, published February 13, 2013 and initiated January 16, 2013. Recalling firm: Actelion Pharmaceuticals U.S., Inc.; Status: Terminated; Reported quantity: 3 Cartons; Lot: Lot #: MA00AD5, Exp: 11/30/2014. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actelion Pharmaceuticals U.S., Inc.
Distributor
CA & VA
Lot
Lot #: MA00AD5, Exp: 11/30/2014
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30. recalled?

Yes. FDA published recall D-143-2013 on February 13, 2013. Reported hazard: Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter